Skip to main content
INNOGENE Co., Ltd. logo

INNOGENE Co., Ltd. — Investor Relations & Filings

Ticker · 344860 ISIN · KR7344860002 KO Manufacturing
Open in API
Filings indexed 144 across all filing types
Latest filing 2025-02-10 Proxy Solicitation & In…
Country KR South Korea
Listing KO 344860

About INNOGENE Co., Ltd.

http://eng.innogene.com

INNOGENE Co., Ltd. is a company specializing in anti-aging solutions. It develops, manufactures, and distributes advanced therapeutic products and cosmetics focused on skin regeneration and hair follicle health. The company's research and development leverages core technologies in medical informatics and a stem cell database to create its product portfolio. These solutions are designed to address concerns related to skin aging and hair loss, based on scientific studies of stem cell applications and healthy beauty.

Recent filings

Filing Released Lang Actions
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice of an upcoming Annual General Meeting (AGM) for the company 'InnoGen'. It details the meeting date, location, agenda items (such as financial statement approval, director appointments, and dividend proposals), and provides biographical details for board nominees. This document is a standard proxy solicitation/notice of meeting sent to shareholders to inform them of the upcoming meeting and request their participation/votes. According to the provided definitions, this fits the 'Proxy Solicitation & Information Statement' (PSI) category.
2025-02-10 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details the resignation of an outside director (CHOI KYOUNG WON) from the company (주)이노진. This falls under the category of changes in the company's board of directors or senior management.
2025-02-04 Korean
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for the purpose of an upcoming Annual General Meeting (AGM). It does not contain the full meeting materials or proxy statements, but rather serves as a formal regulatory notice of the procedural step required for the meeting. Given it is a standard regulatory notification that does not fit into specific categories like 'AGM-R' (which implies presentation materials) or 'PSI' (which implies proxy solicitation materials), it is best classified as a general regulatory filing.
2024-12-11 Korean
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Notice of Dividend Amount Classification · 100% confidence The document is a regulatory announcement from Innogene regarding the closure of the shareholder register to determine eligibility for dividends for the 2024 fiscal year. It explicitly states that this is a notice of the record date for potential future dividends, not the announcement of the dividend amount itself. Since it relates to corporate actions regarding shareholder rights and dividend preparation, and does not fit into specific categories like 'DIV' (which requires a specific amount) or 'RPA', it is best classified as a general regulatory filing.
2024-12-11 Korean
가족친화인증ㆍ유효기간연장ㆍ인증취소(자율공시)
Environmental & Social Information Classification · 100% confidence The document is a voluntary disclosure (자율공시) regarding the extension of a 'Family-Friendly Certification' (가족친화 인증) issued by the Ministry of Gender Equality and Family. It details the certification period, the legal basis, and the company's internal programs. Since this is a regulatory announcement regarding corporate status/compliance that does not fit into specific financial categories like 10-K, ER, or M&A, it is classified as a general regulatory filing.
2024-12-03 Korean
분기보고서 (2024.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company Innogene (주)이노진 for the period ending September 30, 2024. It contains detailed business information, financial data, production statistics, and sales breakdowns. As it is a comprehensive financial report for a period shorter than a full fiscal year, it falls under the 'Interim / Quarterly Report' category. 9M 2024
2024-11-14 Korean

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.